Axonics
- Country
- πΊπΈUnited States
- Ownership
- Public
- Established
- 2012-01-01
- Employees
- 797
- Market Cap
- -
- Website
- http://www.axonics.com
- Introduction
Axonics, Inc. is a medical device company, which engages in developing and commercializing of novel implantable sacral neuromodulation (SNM) devices to treat patients with bladder and bowel dysfunction. Its product Bulkamid, which is a urethral bulking agent used to treat stress urinary incontinence in women. The company was founded by Raymond W. Cohen, Guang Qiang Jiang, and Danny L. Dearen in March 2012 and is headquartered in Irvine, CA.
Clinical Trials
8
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)β’ Click on a phase to view related trials
PMCF Study of the Axonics SNM System Model 5101 (R20)
- Conditions
- Urinary Urge Incontinence (UUI)Urinary Frequency (UF)Overactive Bladder (OAB)
- First Posted Date
- 2025-01-23
- Last Posted Date
- 2025-10-14
- Lead Sponsor
- Axonics, Inc.
- Target Recruit Count
- 55
- Registration Number
- NCT06789406
- Locations
- πΊπΈ
University of Chicago, Chicago, Illinois, United States
π¬π§Bradford Royal Infirmary, Bradford, West Yorkshire, United Kingdom
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
- Conditions
- Overactive BladderUrinary Urgency IncontinenceBenign Prostatic HyperplasiaProstate CancerProstatectomyUrinary Frequency
- First Posted Date
- 2024-07-19
- Last Posted Date
- 2025-10-14
- Lead Sponsor
- Axonics, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT06511141
- Locations
- πΊπΈ
Utica Park Urology, Tulsa, Oklahoma, United States
πΊπΈUniversity of Alabama at Birmingham, Birmingham, Alabama, United States
πΊπΈUrology Associates, Fairhope, Alabama, United States
F15 Recharge Free Axonics SNM System Clinical Study
- Conditions
- Urinary Urge Incontinence (UUI)Urinary Frequency (UF)Fecal Incontinence (FI)
- First Posted Date
- 2024-01-02
- Last Posted Date
- 2025-10-14
- Lead Sponsor
- Axonics, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT06186765
- Locations
- πΊπΈ
Hartford Healthcare, Waterford, Connecticut, United States
πΊπΈFlorida Gulf Clinical Research, Bradenton, Florida, United States
πΊπΈEast Coast Institute of Research, Jacksonville, Florida, United States
Cycling Study With the Axonics System
- Conditions
- Urinary Urge IncontinenceSacral NeuromodulationOveractive Bladder Syndrome
- First Posted Date
- 2022-09-16
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- Axonics, Inc.
- Target Recruit Count
- 31
- Registration Number
- NCT05543382
- Locations
- πΊπΈ
The Florida Bladder Institute, Naples, Florida, United States
πΊπΈLSU Health, New Orleans, Louisiana, United States
πΊπΈUniversity Hospitals-Cleveland Medical Center, Cleveland, Ohio, United States
Axonics SacRal NeuromodulaTIon System RegisTRY Study
- Conditions
- Urinary Urge IncontinenceUrgency-FrequencyUrinary RetentionFecal Incontinence
- First Posted Date
- 2021-10-01
- Last Posted Date
- 2025-09-22
- Lead Sponsor
- Axonics, Inc.
- Target Recruit Count
- 272
- Registration Number
- NCT05064384
- Locations
- πΊπΈ
Arkansas Urology Research Center, Little Rock, Arkansas, United States
πΊπΈUniversity of California, Irvine, Irvine, California, United States
πΊπΈStanford Medicine, Redwood City, California, United States
- Prev
- 1
- 2
- Next